Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2011

01-12-2011 | Original Article

Salivary total antioxidant capacity in type 2 diabetes mellitus patients—a clinical and biochemical study amongst tobacco smokers

Authors: Roopashri Rajesh Kashyap, Gopakumar R. Nair, Subhas Babu Gogineni, Kumari N. Suchetha

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2011

Login to get access

Abstract

This study was undertaken to determine the effect of smoking and diabetes mellitus individually and combined on the total antioxidant capacity (TAC) of saliva in type 2 diabetes mellitus. The study consisted of four groups, one control and three study groups, each with 20 subjects. Salivary and serum samples were collected from all the groups, which were further subjected to biochemical analysis. The observations of the study were subjected to statistical analysis using SPSS software version 12. The level of salivary TAC decreases secondary to diabetes mellitus and smoking. As the duration of diabetes mellitus increases, the level of total antioxidants decreases. Correlation of salivary TAC with Russell’s index had a negative correlation. Smoking has a synergistic effect on diabetes mellitus in reducing the salivary total antioxidant level. Further research should be devoted to the possible benefits of supplementation with antioxidant supplements. Saliva is considered to be a representative of serum and salivary analysis is simple and noninvasive. From the clinical standpoint, it may be reasonable to conclude that salivary TAC can be a useful marker to assess the oxidative stress, as an indicator of progression of diabetes mellitus.
Literature
1.
go back to reference Ametican Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62–9.CrossRef Ametican Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62–9.CrossRef
2.
go back to reference Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 1999;48:1414–7.PubMedCrossRef Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism. 1999;48:1414–7.PubMedCrossRef
3.
go back to reference Reznick AZ, Shehadeh N, Shafir Y, Nagler RM. Free radicals related effects and antioxidants in saliva and serum of adolescents with type 1 diabetes mellitus. Arch Oral Biol. 2006;51:640–8.PubMedCrossRef Reznick AZ, Shehadeh N, Shafir Y, Nagler RM. Free radicals related effects and antioxidants in saliva and serum of adolescents with type 1 diabetes mellitus. Arch Oral Biol. 2006;51:640–8.PubMedCrossRef
4.
go back to reference Garg N, Singh R, Dixit J, Jain A, Tewari V. Levels of lipid peroxides and antioxidants in smokers and nonsmokers. J Periodontal Res. 2006;41:405–10.PubMedCrossRef Garg N, Singh R, Dixit J, Jain A, Tewari V. Levels of lipid peroxides and antioxidants in smokers and nonsmokers. J Periodontal Res. 2006;41:405–10.PubMedCrossRef
5.
go back to reference Kanehira T, Shibata K, Kashiwazaki H, Inoue N, Morita M. Comparison of antioxidant enzymes in saliva of elderly smokers and non-smokers. Gerodontology. 2006;23:38–42.PubMedCrossRef Kanehira T, Shibata K, Kashiwazaki H, Inoue N, Morita M. Comparison of antioxidant enzymes in saliva of elderly smokers and non-smokers. Gerodontology. 2006;23:38–42.PubMedCrossRef
6.
go back to reference Sherwin RS. Diabetes mellitus, Cecil textbook of medicine. 22nd ed. Philadelphia: Saunders; 1996. p. 1258–60. Sherwin RS. Diabetes mellitus, Cecil textbook of medicine. 22nd ed. Philadelphia: Saunders; 1996. p. 1258–60.
7.
go back to reference Peter S. Essentials of preventive and community dentistry. 2nd ed. New Delhi: Arya (medi) Publishing House; 2003. p. 159–61. Peter S. Essentials of preventive and community dentistry. 2nd ed. New Delhi: Arya (medi) Publishing House; 2003. p. 159–61.
8.
go back to reference Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin e. Anal Biochem. 1999;269:337–41.PubMedCrossRef Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin e. Anal Biochem. 1999;269:337–41.PubMedCrossRef
9.
go back to reference Battino M, Ferreiro MS, Gallardo I, Newman HN, Bullon P. The antioxidant capacity of saliva. J Clin Periodontol. 2002;29:189–94.PubMedCrossRef Battino M, Ferreiro MS, Gallardo I, Newman HN, Bullon P. The antioxidant capacity of saliva. J Clin Periodontol. 2002;29:189–94.PubMedCrossRef
10.
go back to reference Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 2002;32:268–77.PubMedCrossRef Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 2002;32:268–77.PubMedCrossRef
11.
go back to reference Zappacosta B, Persichilli S, De Sole P, Mordente A, Giardina B. Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers. Arch Oral Biol. 1999;44:485–8.PubMedCrossRef Zappacosta B, Persichilli S, De Sole P, Mordente A, Giardina B. Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers. Arch Oral Biol. 1999;44:485–8.PubMedCrossRef
12.
go back to reference Zloczower M, Reznick AZ, Zouby RO, Nagler RM. Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes? Antioxid Redox Signal. 2007;9:765–73.PubMedCrossRef Zloczower M, Reznick AZ, Zouby RO, Nagler RM. Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes? Antioxid Redox Signal. 2007;9:765–73.PubMedCrossRef
13.
go back to reference Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci. 2003;105:167–72.PubMedCrossRef Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci. 2003;105:167–72.PubMedCrossRef
14.
go back to reference Boemi M, Sirolla C, Testa R, Cenerelli S, Fumelli P, James RW. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in type 2 diabetic patients. Diabet Med. 2004;21:423–7.PubMedCrossRef Boemi M, Sirolla C, Testa R, Cenerelli S, Fumelli P, James RW. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in type 2 diabetic patients. Diabet Med. 2004;21:423–7.PubMedCrossRef
Metadata
Title
Salivary total antioxidant capacity in type 2 diabetes mellitus patients—a clinical and biochemical study amongst tobacco smokers
Authors
Roopashri Rajesh Kashyap
Gopakumar R. Nair
Subhas Babu Gogineni
Kumari N. Suchetha
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0043-1

Other articles of this Issue 4/2011

International Journal of Diabetes in Developing Countries 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.